Relief of intractable pruritus with romidepsin in patients with cutaneous T-cell lymphoma: A series of four cases.

Poligone, Brian; Rubio-Gonzalez, Belen; Querfeld, Christiane

Poligone, Brian; Rubio-Gonzalez, Belen; Querfeld, Christiane.

Affiliation

Poligone B; Rochester Skin Lymphoma Center, Fairport, New York.
Rubio-Gonzalez B; City of Hope Comprehensive Cancer Center, Cutaneous Lymphoma Program, Toni Stephenson Lymphoma Center, Duarte, California.
Querfeld C; City of Hope Comprehensive Cancer Center, Cutaneous Lymphoma Program, Toni Stephenson Lymphoma Center, Duarte, California.

Dermatol Ther ; 32(2): e12804, 2019 03.

Article in En | MEDLINE | ID: mdl-30549384

Subject(s)

Depsipeptides/administration & dosage; Lymphoma, T-Cell, Cutaneous/drug therapy; Pruritus/drug therapy; Skin Neoplasms/drug therapy; Adult; Aged; Depsipeptides/adverse effects; Dose-Response Relationship, Drug; Female; Histone Deacetylase Inhibitors/administration & dosage; Histone Deacetylase Inhibitors/adverse effects; Humans; Lymphoma, T-Cell, Cutaneous/pathology; Male; Middle Aged; Pruritus/etiology; Quality of Life; Skin Neoplasms/pathology

Key words

cutaneous T-cell lymphoma; lenalidomide; pruritus; romidepsin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pruritus / Skin Neoplasms / Lymphoma, T-Cell, Cutaneous / Depsipeptides Type of study: Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2019 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google